Eculizumab for the treatment of pregnancy-related atypical hemolytic uremic syndrome.
about
Critical appraisal of eculizumab for atypical hemolytic uremic syndromeAdvances and challenges in the management of complement-mediated thrombotic microangiopathiesDirect evidence of complement activation in HELLP syndrome: A link to atypical hemolytic uremic syndrome.A Case Report and Literature Review of Eculizumab Withdrawal in Atypical Hemolytic-Uremic SyndromeComplement-mediated thrombotic microangiopathy secondary to sepsis-induced disseminated intravascular coagulation successfully treated with eculizumab: A case report.Atypical hemolytic uremic syndrome in the setting of complement-amplifying conditions: case reports and a review of the evidence for treatment with eculizumab.Current evidence on the discontinuation of eculizumab in patients with atypical haemolytic uraemic syndrome.Pregnant Woman with Atypical Hemolytic Uremic Syndrome Delivered a Healthy Newborn under Eculizumab Treatment.Acute Kidney Injury in Pregnancy.Maternal and Fetal Outcomes of Pregnancies in Women with Atypical Hemolytic Uremic Syndrome.Hemolytic Uremic Syndrome in Pregnancy and Postpartum.
P2860
Q26750692-AE7BBAF3-1B91-4EA7-B094-30F29FC44C59Q26796453-BEA24BB9-40DD-4164-A616-5ACEE3D48680Q33430320-15582A2C-7A4F-4DDE-99A8-137726CB7ABAQ33437634-89D7688C-6803-4861-B9A9-DE2B972445B6Q33439152-D8D24D06-4ECA-4A3E-B68D-0208BFC04EE8Q33705135-EE87D6DD-4F02-4AB4-9335-86649DAE1D5AQ33783126-796CB3E8-4F97-465A-8C24-18EFB1153DE5Q37563002-1B8D25C1-6F0A-4E40-AFC6-CF75DF2C8916Q39436556-8BD390D5-9E14-4636-BE77-47BBBF20DC1EQ47251151-84AA184A-2581-48BF-A2B6-3BB7FC86D7CFQ47736433-1988C734-56E1-4984-BCEE-CB9AD50D5513
P2860
Eculizumab for the treatment of pregnancy-related atypical hemolytic uremic syndrome.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Eculizumab for the treatment of pregnancy-related atypical hemolytic uremic syndrome.
@en
Eculizumab for the treatment of pregnancy-related atypical hemolytic uremic syndrome.
@nl
type
label
Eculizumab for the treatment of pregnancy-related atypical hemolytic uremic syndrome.
@en
Eculizumab for the treatment of pregnancy-related atypical hemolytic uremic syndrome.
@nl
prefLabel
Eculizumab for the treatment of pregnancy-related atypical hemolytic uremic syndrome.
@en
Eculizumab for the treatment of pregnancy-related atypical hemolytic uremic syndrome.
@nl
P2093
P2860
P1433
P1476
Eculizumab for the treatment of pregnancy-related atypical hemolytic uremic syndrome.
@en
P2093
Aima Lancharro
Azucena Pajares
Carolina Cañigral
Cristina Castro
Federico Moscardó
Nelly Carpio
Pilar Solves
P2860
P304
P356
10.1007/S00277-013-1970-3
P577
2013-12-05T00:00:00Z